SB
Sutro Biopharma
🇺🇸XNAS.STROUnited StatesHealthcare
$16.22USDdown -0.34 (-2.05%)OpenDelayed3:55 PM
Price$16.22-0.34 (-2.05%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US8693672011
- CUSIP
- 869367102
Company
- Employees
- 128
- Headquarters
- South San Francisco, United States
- Website
- https://www.sutrobio.com
- CEO
- Ms. Jane Chung R.Ph.
Market
- Shares outstanding
- 16.6M
- Market cap
- $268.95M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $271.43M
- EPS LTM
- -$10.89calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -1.49calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $45.7M-56.25%down year on year
- Net income
- -$180.64M+13.45%up year on year
- Gross margin
- 89.49%-8.8%down year on year
- Free cash flow
- -$145.62M+42.22%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.